Find a Doctor

To find your closest EVO Visian ICL doctor, start by searching your location.

    This provider locator tool is being provided by STAAR Surgical Company (“STAAR”) solely to assist you in locating a provider who has experience with the EVO ICL family of lenses. For your convenience and based on your election, STAAR may highlight certain providers in your area who are frequent users of EVO ICL lenses. Notwithstanding the above, this provider locator tool should not be construed in any way as an endorsement or recommendation by STAAR as to the qualifications of any provider listed in this tool or the quality of medical care they can provide. STAAR makes no guarantees that using a provider from this list will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential provider. STAAR recommends that you meet and discuss the benefits and risks of the EVO ICL lens, and the procedure to implant the EVO ICL lens with the potential provider.


    STAAR hereby disclaims any and all liability arising from your use of and/or reliance on the information contained in this provider locator tool.

    Important Safety Information

    The EVO Visian ICL Lens is intended for the correction of moderate to high nearsightedness. EVO Visian ICL and EVO Visian TICL surgery is intended to safely and effectively correct nearsightedness between -3.0 D to -15.0 D, the reduction in nearsightedness up to -20.0 D and treatment of astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before.

    Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care professional. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts.

    You should NOT have EVO Visian ICL surgery if:

    • Your doctor determines that the shape of your eye is not an appropriate fit for the EVO Visian ICL
    • You are pregnant or nursing
    • You have moderate to severe damage to the optic nerve caused by increased pressure (glaucoma)
    • You do not meet the minimum endothelial cell density for your age at the time of implantation as determined by your eye doctor
    • Your vision is not stable as determined by your eye doctor

    Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. For additional information with potential benefits, risks and complications please visit DiscoverICL.com.

    References

    References

    1Patient Survey, STAAR Surgical ICL Data Registry, 2018

    2Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46.

    3Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

    4Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

    5aLee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

    5bParkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

    *American Refractive Surgery Council